Advertisement
-
1
Kelley WN, Schumacher HR: “Crystal-Associated Synovitis,” in Textbook of Rheumatology, 4th Ed, Vol 2, edited by WN Kelley, p 1291, WB Saunders, Philadelphia, 1993.
-
2
Resnick D, Broderick TW: Intraosseous calcifications in tophaceous gout. AJR Am J Roentgenol 17: 1157, 1981.
-
3
Liu SZ, Yeh L, Chou YJ, et al.: Isolated intraosseous gout in hallux sesamoid mimicking a bone tumor in a teenaged patient. Skeletal Radiol 32: 647, 2003.
-
4
Oti FE, Reichert B, Bär I: Intraosseous tophaceous gout in the proximal phalanx of he small finger. J Hand Surg Eur Vol 37: 696, 2012.
-
5
Melloni P, Valls R, Yuguero M, et al.: Unusual imaging manifestations of intraosseous tophaceous gout of the patella. J Rheumatol 32: 959, 2005.
-
6
Morino T, Fujita M, Kariyama K, et al.: Intraosseous gouty tophus of the talus, treated by total curettage and calcium phosphate cement filling: a case report. Foot Ankle Int 28: 126, 2007.
-
7
Yun CH, Shih SL, Fang YK, et al.: Juvenile intraosseous gout of the calcaneus. Pediatr Radiol 35: 899, 2005.
-
8
Cheung A, Allardice G: Intraosseous talar pseudotumour: an unusual presentation of gout. Foot (Edinb) 23: 86, 2013.
-
9
Su CH, Hung JK: Intraosseous gouty tophus in the talus: a case report. J Foot Ankle Surg 55: 288, 2016.
-
10
Foucar E, Buckwalker J, El-Khoury GY: Gout presenting as a femoral cyst. J Bone Joint Surg Am 66: 29, 1984.
-
11
Cope R, Marsan R, Castelli MJ: Case report 732: gout presenting as a large pseudo tumor (tophus) in the proximal end of the tibia. Skeletal Radiol 21: 269, 1992.
-
12
Gentili A: Advanced imaging of gout. Semin Musculoskeletal Radiol 7: 165, 2003.
Intraosseous Gouty Osteolytic Lesion in Calcaneus
Tophaceous gout often occurs in soft tissues, and gouty invasion to the bone is rare. To date, only one case of isolated intraosseous gouty invasion to the calcaneus has been reported. We report here a rare case of an intraosseous calcaneal gouty cystic lesion treated with curettage and allogenous and autogenous bone graft. Satisfactory function and pain relief were obtained at 12-month follow-up, without any evidence of recurrent disease.
